Almokalant is a selective class III antiarrhythmic agent primarily investigated for the treatment of atrial fibrillation by blocking potassium channels to prolong cardiac repolarization. As a potent pharmacologically… Read more
Almokalant is a selective class III antiarrhythmic agent primarily investigated for the treatment of atrial fibrillation by blocking potassium channels to prolong cardiac repolarization. As a potent pharmacologically active compound, precise identification and quantification are critical in pharmaceutical research. This category includes high-quality reference standards of the parent drug, alongside its related impurities and metabolites, which are essential for accurate impurity profiling and method validation. Laboratories utilize these stable isotope labelled compounds as internal standards during bioanalytical mass spectrometry to ensure assay sensitivity, selectivity, and regulatory compliance. By incorporating these materials into routine analytical testing and quality control workflows, researchers can effectively monitor drug stability, degradation pathways, and pharmacokinetic parameters, ensuring the integrity and safety of pharmaceutical development processes.